Steering Committee Membership

The Committee has nominated representatives from Chemical Pathologists, Biochemists and Medical Laboratory Scientific Officers. Three nominations are made by the Specialist Standing Advisory Group in Clinical Chemistry (SSAGCC), a sub-group of the Welsh Scientific Advisory Committee, and one representative from the National Quality Assurance Advisory Panel in Chemical Pathology (Panel).

• Mr Peter Breadon, Chemical Pathology Department, Southport Hospital.- NQAAP representative.

• Mr Dave Ducroq, Deputy Director, WEQAS.

• Dr Jenny Frost, Deputy Chief Scientific Adviser, Welsh Assembly Government.

• Dr David Hullin, Consultant Clinical Biochemist, Royal Glamorgan Hospital, Ynysmaerdy, Pontyclun. Chairman of the Steering Committee.

• Dr Garry John, Consultant Biochemist, Department of Clinical Biochemistry, Norfolk and Norwich University Hospital, Norwich.

• Dr Rhys John, Consultant Clinical Biochemist in Endocrinology, University Hospital of Wales.

• Professor Jonathan Kay, Chemical Pathologist, Department of Clinical Biochemistry, John Radcliffe Hospital, Oxford.

• Mr David Stockwell, Laboratory Manager, Department of Chemical Pathology, Morgannwg NHS Trust - IBMS representative.

• Mrs Annette Thomas, Consultant Clinical Biochemist and Director of Quality Laboratory.

• Mr Tony Currell, Clinical Biochemistry Service Manager, Whiston Hospital, Merseyside - IBMS representative.

• Mr Neil Formstone, Lay Member of the Royal college of Pathologists - Patient representative.
• Miss Rebecca Dowdeswell, Steering Comittee Secretary.

      Advisors:

• Mr Huw Mitchell, Department of Medical Oncology, Charing Cross Hospital, London.

• Dr Mike Badminton, Porphyrin Reference Unit, University Hospital of Wales, Cardiff.